Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Stem cell death gives clue to brain cell survival


A signal that triggers half the stem cells in the developing brain to commit suicide at a stage where their survival will likely do more harm than good has been identified by researchers at the Medical College of Georgia and the University of Georgia.

Identifying the factors that result in the timely, massive cell suicide is important to understanding the developmental puzzle, the researchers say of the work featured on the cover of the Aug. 4 issue of the Journal of Cell Biology.

They say it also gives clues about cell death - and the brain´s possible recovery - in devastating diseases such as Alzheimer´s, Parkinson´s and stroke. MCG´s Erhard Bieberich and UGA´s Brian G. Condie have found that the lipid ceramide and the protein PAR-4 - each already implicated for playing a role in cell death - become deadly partners inside a dividing stem cell in the developing mouse brain.

"If PAR-4 is there and ceramide is high, the cell is lost, doomed to die," says Dr. Bieberich, biochemist at the Medical College of Georgia. "You can eliminate one of them, you can knock down the expression of PAR-4 or ceramide and the other stays up but the cell doesn´t die. But if both signals are together up-regulated, then the cell is destined to die."

At a certain point in cell division, just before neurons begin forming, there is massive production of proteins and up-regulation of lipids. During that phase, decisions are made about which daughter cells get what composition of lipids and proteins, decisions that affect the cells´ future function.

Typically at this point in division, the two daughter cells birthed from a single stem cell will have the same makeup and the same ultimate purpose.

Yet in a subpopulation of the stem cells involved in brain development, the scientists have documented increasing levels of ceramide in both resulting daughter cells while its death partner, PAR-4, gets handed off to only half the cells.

Cells destined to survive, and likely further divide and differentiate, are handed instead a protein called nestin. "Nestin is a marker for a particular stage of neuronal development," says Dr. Bieberich. "Nestin-bearing cells will develop into neural cells such as our neurons or astrocytes or other cells. So it makes sense that the cells that inherit nestin, but not PAR-4, will survive and develop into normal neuronal cells whereas the other ones will die."

It also makes sense that the lethal coupling that signals cell suicide, or apoptosis, comes at a point where the doomed cells seem to have lost their potential usefulness and where their continued survival would result in a malformed brain.

"During normal development in the central nervous system there is a great deal of cell death that occurs that seems to be required to create the final shape and structure of the brain," says Dr. Condie, developmental neurobiologist at the University of Georgia and MCG. "In cases where that process has been interfered with, you end up with this excess of cells that leads to a malformation of the developing brain.

"One of the ideas behind why there is an excess of cells generated during development is that it may be a mechanism for compensating for environmental stresses or other types of stresses that an embryo may encounter during development," says Dr. Condie. "So you actually generate an excess of the cells you need and then prune those cells back to an appropriate number and location for the brain to develop in a normal fashion." It´s a typical characteristic of embryonic development for certain cells to survive and others to die, he says.

"During embryonic development, we would like to know how stem cell death is regulated because we know it needs to be regulated," says Dr. Bieberich. "You don´t want the whole brain dying or overgrowing. You have to find a balance. How is that balanced maintained? What are the secrets for that?

"We have designed experiments showing that these two signals are necessary to make stem cells die, but you are talking about a whole signaling cascade that starts out with ceramide and PAR-4 and then there are a lot of unknown steps until we end up with the actual death of a cell," says Dr. Bieberich.

The MCG researcher recently received a grant from the National Institutes of Health so he and Dr. Condie can explore these unknowns such as how the expression of PAR-4 and ceramide is regulated, what accounts for the asymmetrical distribution of PAR-4 and just how the deadly duo interact.

But the two are excited about what they have found already. "If we don´t know the signals, we don´t know where to begin," says Dr. Bieberich.

They also are intrigued by where the work may lead, including helping minimize cell death that occurs when stem cells in the adult brain begin to once again divide in response to a stroke, as an example.

"We all know that even in adulthood, we have stem cells in the brain and they may be able to repair damaged areas," says Dr. Bieberich. "But if the same cell death mechanisms are still active, there will not be an increase in the number of stem cells because always one cell will die and one will survive. Maybe we can control this and increase the number of endogenous stem cells.

"Also during the neurodegeneration that occurs in diseases such as Alzheimer´s and Parkinson´s, we have a lot of cell death going on and we would like to know what signals are involved that make those brain cells die. They may be very similar or even exactly the same as the ones we investigate with our embryonic mouse stem cells."

Study co-authors include Scott Noggle, an MCG graduate student working with Dr. Condie at UGA; Sarah MacKinnon, a former participant in MCG´s summer research programs for undergraduates who is now a graduate student at the University of Virginia; and Dr. Jeane Silva, Dr. Bieberich´s research coordinator.

Contact: Phil Williams, (+1) 706-542-8501

Phil Williams | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>